Ask Warren

PeopleBio

304840 · KOSDAQ · ₩304840 · 피플바이오

₩561 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩1.7B₩643M₩154M₩1.2B₩733M₩780M₩658M₩962M
Cost of sales₩724M₩404M₩1.3B₩620M₩598M₩760M₩210M₩867M
Gross profit₩945M₩240M−₩1.2B₩565M₩135M₩20M₩448M₩95M
Operating income−₩749M−₩1.5B−₩1.7B−₩2.1B−₩2B−₩2.6B−₩1.9B−₩3.3B
Net income₩111M−₩2.1B−₩11B−₩1.2B−₩1.3B−₩3.3B−₩1.8B−₩3.4B
Net income to shareholders−₩1.9B−₩2.1B−₩10B−₩1.1B−₩1.5B−₩2.9B−₩1.7B−₩3.1B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩110B₩47B₩45B₩20B₩22B₩25B₩27B₩30B
Current assets₩3.5B₩7.2B₩4.4B₩11B₩13B₩15B₩17B₩19B
Cash and equivalents₩302M₩3B₩80M₩577M₩186M₩1.2B₩1.3B₩638M
Total liabilities₩81B₩18B₩16B₩18B₩19B₩20B₩19B₩21B
Current liabilities₩79B₩16B₩14B₩15B₩16B₩17B₩17B₩17B
Borrowings₩76B₩13B₩7.4B₩10B₩9.5B₩9B₩8.5B₩9.6B
Total equity₩29B₩30B₩29B₩1.7B₩3B₩4.3B₩7.6B₩9.3B
Shareholders' equity₩29B₩30B₩29B₩2.9B₩4.1B₩5.5B₩8.4B₩9.9B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩557M−₩1.7B−₩1.2B−₩1.5B−₩1.1B−₩1.4B−₩1.8B−₩5.8B
Capital spending₩4.9B₩0₩72M₩0₩142M₩0₩0₩17M
Free cash flow−₩5.4B−₩1.7B−₩1.3B−₩1.5B−₩1.2B−₩1.4B−₩1.8B−₩5.8B

Consolidated where available. Amounts in won.

Also known as: PeopleBio / 피플바이오 / 304840 / KRX:304840

Source: KRX statistical information